Pharmacokinetic Interactions (ADME Breakdown); Pharmacodynamic Interactions

0.0(0)
Studied by 0 people
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/41

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 3:47 AM on 8/26/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

42 Terms

1
New cards

Absorption Interactions

Alterations in GI solubility, transit time, or active efflux transporters reduce or accelerate bioavailability.

Gastric pH Alteration

Chelation & Complexation

GI Motility Shifts

P-Glycoprotein (P-gp) Inhibition

2
New cards

Gastric pH Alteration

Weakly acidic drugs require an acidic gastric pH to remain non-ionized and soluble for absorption. Antacids, H2 blockers, and PPIs raise pH, stopping dissolution.

3
New cards

Chelation & Complexation

Polyvalent cations bind drugs, forming an insoluble ring structure that cannot cross the intestinal wall.

4
New cards

P-Glycoprotein (P-gp) Inhibition

Prokinetic agents speed gastric emptying (delivering drugs to the small intestine faster); anticholinergics slow transit time

5
New cards

P-Glycoprotein (P-gp) Inhibition

P-gp is an efflux pump in intestinal enterocytes that pumps drugs back into the lumen. Inhibiting P-gp dramatically increases oral absorption.

6
New cards

Gastric pH Alteration: example

Omeprazole + Ketoconazole / Itraconazole

Result: Decreased antifungal absorption and treatment failure.



7
New cards

Chelation & Complexation: Example

Antacids / Milk + Tetracyclines or Ciprofloxacin


Result: Over 80% reduction in antibiotic absorption.

8
New cards

GI Motility Shifts: Example

Metoclopramide + Acetaminophen (accelerates absorption) vs. Atropine + Morphine (delays absorption).

9
New cards

P-Glycoprotein (P-gp) Inhibition: Example

Verapamil / Amiodarone / Clarithromycin + Digoxin


Result: Increased Digoxin absorption Digoxin Toxicity.

10
New cards

Plasma Protein Displacement

Only unbound (free) drug is pharmacologically active and capable of causing toxicity. Displacing 1–2% of a highly bound drug can double its active free concentration.

11
New cards
12
New cards

Kernicterus

Other Displacements: Sulfonamides displace Bilirubin from albumin in neonates → ‘blank’ (encephalopathy).

13
New cards

Excretion Interactions

Occur primarily in the renal tubules through competition for active secretion transporters or alteration of urinary pH.

Renal Tubular Competition

Renal Hemodynamics & Lithium Toxicity

Urinary Ion Trapping

14
New cards

Renal Tubular Competition

Probenecid blocks the Organic Anion Transporter (OAT) in the proximal tubule.

Application: Given with Penicillin to prolong penicillin's half-life; causes toxicity when co-administered with Methotrexate.


15
New cards

Renal Hemodynamics & Lithium Toxicity

Lithium is handled like Sodium in the proximal tubule.

16
New cards

Sodium depletion

Thiazide Diuretics, NSAIDs, or ACE inhibitors cause ‘blank’ → proximal tubule reabsorbs more Sodium AND LithiumSevere Lithium Toxicity (tremors, ataxia, seizures)

17
New cards

Alkalinization (Sodium Bicarbonate)

Ionizes weak acids (Aspirin, Phenobarbital), forcing clearance during overdose

18
New cards

Acidification (Ammonium Chloride / Ascorbic Acid)

Ionizes weak bases (Amphetamines, Quinidine), driving urinary elimination.

19
New cards

Benzodiazepines + Alcohol / Opioids: interaction type, Dangerous clinical outcome

Interaction Type: Additive GABAa/ Mu-receptor CNS depression

Dangerous Clinical Outcome: Severe respiratory depression, coma, death

20
New cards

Sildenafil + Nitroglycerin: interaction type, Dangerous clinical outcome

Interaction Type: Synergistic cGMP accumulation

Dangerous Clinical Outcome: Precipitous drop in blood pressure Severe shock/MI.

21
New cards

ACE Inhibitor + Spironolactone: interaction type, Dangerous clinical outcome

Interaction Type: Additive Potassium retention

Dangerous Clinical Outcome: Life-threatening Hyperkalemia Cardiac arrest.

22
New cards

Aminoglycoside + Furosemide: interaction type, Dangerous clinical outcome

Interaction Type: Additive Ototoxicity & Nephrotoxicity

Dangerous Clinical Outcome: Permanent deafness and acute tubular necrosis

23
New cards

MAO Inhibitor + SSRI / Meperidine: interaction type, Dangerous clinical outcome

Interaction Type: Excessive Synaptic Serotonin accumulation

Dangerous Clinical Outcome: Serotonin Syndrome (hyperthermia, rigidity, myoclonus).

24
New cards

Propranolol + Salbutamol: Interaction mechanism, Clinical consequence

Interaction Mechanism: Non-selective B-blocker competes with B2-agonist
Clinical Consequence: Severe bronchospasm in asthmatic patients.

25
New cards

Morphine + Naloxone: Interaction mechanism, Clinical consequence

Interaction Mechanism: Competitive antagonism at mu-opioid receptors
Clinical Consequence: Instant reversal of analgesia and opioid respiratory depression.


26
New cards

NSAIDs + Antihypertensives: Interaction mechanism, Clinical consequence

Interaction Mechanism: NSAIDs block renal prostaglandin synthesis (PGE2/ PGI2)
Clinical Consequence: Sodium/water retention that blunts the efficacy of ACEi, Diuretics, and B-blockers

27
New cards

Warfarin + Vitamin K: Interaction mechanism, Clinical consequence

Interaction Mechanism: Vitamin K bypasses Warfarin's blockade of VKORC1
Clinical Consequence: Complete loss of Warfarin anticoagulation (clot risk)

28
New cards

Tyramine-Rich Foods + MAO Inhibitors (Phenelzine, Tranylcypromine)

Hypertensive Crisis ("Cheese Effect" — triggered by aged cheese, red wine, cured meats).

29
New cards

Grapefruit Juice + Calcium Channel Blockers / Statins

Inhibits intestinal CYP3A4, increasing oral bioavailability by 200- 400%

30
New cards

St. John’s Wort + Cyclosporine / Digoxin / Warfarin

CYP3A4 and P-glycoprotein, causing organ transplant rejection (Cyclosporine failure) or loss of anticoagulation

31
New cards

Ginkgo Biloba / Garlic / Ginseng + Anticoagulants

Antiplatelet properties that additively increase bleeding risks without altering INR values

32
New cards

Digoxin + Amiodarone

Primary Mechanism: P-gp Inhibition & Reduced Clearance

PHLE board exam result: Digoxin Toxicity (Yellow-green halos, arrhythmias).

33
New cards

Lithium + Hydrochlorothiazide

Primary Mechanism: Reduced Renal Clearance via Na+ Depletion

PHLE board exam result: Lithium Toxicity (Ataxia, coarse tremors).

34
New cards

Warfarin + Trimethoprim-Sulfa

Primary Mechanism: CYP2C9 Inhibition & Protein Displacement

PHLE board exam result: Severe Bleeding / Soaring INR.

35
New cards

Methotrexate + NSAIDs

Primary Mechanism: Inhibition of Renal Transporters (OAT)

PHLE board exam result: Bone Marrow Suppression (Pancytopenia)

36
New cards

Terfenadine / Cisapride + Ketoconazole

Primary Mechanism: PCYP3A4 Inhibition leading to accumulation

PHLE board exam result: Torsades de Pointes (Fatal QT prolongation)

37
New cards

Metformin + Radiocontrast Dye

Primary Mechanism: Contrast-induced Acute Kidney Injury

PHLE board exam result: Severe Lactic Acidosis.

38
New cards

Check the Enzyme Type

If an item mentions Rifampicin, Phenytoin, or Carbamazepine, look for an answer describing decreased drug efficacy or treatment failure

39
New cards

Check the Elimination Path

If an item involves Lithium, Digoxin, or Methotrexate, look for a second drug that impairs renal clearance (Diuretics, NSAIDs, Transporter Inhibitors).

40
New cards

Differentiate Bleeding Mechanics

Warfarin + Enzyme Inhibitor (e.g., Metronidazole)

Warfarin + Aspirin/NSAID

41
New cards

Warfarin + Enzyme Inhibitor (e.g., Metronidazole)

Increases INR and causes bleeding.

42
New cards

Warfarin + Aspirin/NSAID

Increases bleeding risk via direct antiplatelet/ulcerogenic effects without changing the INR value.